35 related articles for article (PubMed ID: 15973457)
1.
Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
[TBL] [Abstract][Full Text] [Related]
2. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia: an overview.
Chi Y; Lindgren V; Quigley S; Gaitonde S
Arch Pathol Lab Med; 2008 Nov; 132(11):1835-7. PubMed ID: 18976025
[TBL] [Abstract][Full Text] [Related]
3. The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation.
Oancea C; Rüster B; Henschler R; Puccetti E; Ruthardt M
Leukemia; 2010 Nov; 24(11):1910-9. PubMed ID: 20827285
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis.
Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A
Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180
[TBL] [Abstract][Full Text] [Related]
5. [Clinical observation on 16 cases of DEK-NUP214 fusion gene positive acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation].
Xia J; Zhao Y; Wu XJ; Qiu HY; Tang XW; Wang Y; Jin ZM; Miao M; Ma X; Wu DP; Chen SN; Chen F
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1041-1044. PubMed ID: 38503531
[No Abstract] [Full Text] [Related]
6. Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation.
Bogdanov K; Kudryavtseva E; Fomicheva Y; Churkina I; Lomaia E; Girshova L; Osipov Y; Zaritskey A
Pathophysiology; 2023 Aug; 30(3):296-313. PubMed ID: 37606386
[TBL] [Abstract][Full Text] [Related]
7. Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis.
Greene AN; Solomon MB; Privette Vinnedge LM
Front Aging Neurosci; 2022; 14():1018180. PubMed ID: 36275000
[TBL] [Abstract][Full Text] [Related]
8. A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.
Hao Q; Zhang Q; Li C; Wei S; Li Q; Song Y; Mi Y
Oncol Lett; 2017 Dec; 14(6):7021-7024. PubMed ID: 29344131
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer.
Pease NA; Wise-Draper T; Privette Vinnedge L
J Oncol; 2015; 2015():106517. PubMed ID: 26425120
[TBL] [Abstract][Full Text] [Related]
10.
Zhou MH; Yang QM
Oncol Lett; 2014 Sep; 8(3):959-962. PubMed ID: 25120641
[TBL] [Abstract][Full Text] [Related]
11. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H
Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146
[TBL] [Abstract][Full Text] [Related]
12. Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.
Wang DM; Liu L; Fan L; Zou ZJ; Zhang LN; Yang S; Li JY; Xu W
Cancer Biol Ther; 2012 Dec; 13(14):1522-8. PubMed ID: 23052131
[TBL] [Abstract][Full Text] [Related]
13. The nuclear envelope environment and its cancer connections.
Chow KH; Factor RE; Ullman KS
Nat Rev Cancer; 2012 Feb; 12(3):196-209. PubMed ID: 22337151
[TBL] [Abstract][Full Text] [Related]
14. Control of tumorigenesis and chemoresistance by the DEK oncogene.
Riveiro-Falkenbach E; Soengas MS
Clin Cancer Res; 2010 Jun; 16(11):2932-8. PubMed ID: 20501624
[TBL] [Abstract][Full Text] [Related]
15. Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.
Zheng J; Kohler ME; Chen Q; Weber J; Khan J; Johnson BD; Orentas RJ
BMC Immunol; 2007 Mar; 8():4. PubMed ID: 17397536
[TBL] [Abstract][Full Text] [Related]
16. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.
Garçon L; Libura M; Delabesse E; Valensi F; Asnafi V; Berger C; Schmitt C; Leblanc T; Buzyn A; Macintyre E
Leukemia; 2005 Aug; 19(8):1338-44. PubMed ID: 15973457
[TBL] [Abstract][Full Text] [Related]
17. A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.
Østergaard M; Stentoft J; Hokland P
Leuk Res; 2004 Nov; 28(11):1213-5. PubMed ID: 15380347
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
